Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Infect Disord Drug Targets ; 19(1): 73-80, 2019.
Article in English | MEDLINE | ID: mdl-29366429

ABSTRACT

BACKGROUND: In recent years, very few effective drugs against Mycobacterium tuberculosis have emerged, which motivates the research with drugs already used in the treatment of tuberculosis. Ethambutol is a bacteriostatic drug that affects cell wall integrity, but the effects of this drug on bacilli are not fully exploited. OBJECTIVE: Based on the need to better investigate the complex mechanism of action of ethambutol, our study presented the proteome profile of M. tuberculosis after different times of ethambutol exposure, aiming to comprehend the dynamics of bacilli response to its effects. M. tuberculosis was exposed to ½ MIC of ethambutol at 24 and 48 hours. The proteins were identified by MALDI-TOF/TOF. RESULTS: The main protein changes occurred in metabolic proteins as dihydrolipoyl dehydrogenase (Rv0462), glutamine synthetase1 (Rv2220), electron transfer flavoprotein subunit beta (Rv3029c) and adenosylhomocysteinase (Rv3248c). CONCLUSION: Considering the functions of these proteins, our results support that the intermediary metabolism and respiration were affected by ethambutol and this disturbance provided proteins that could be explored as additional targets for this drug.


Subject(s)
Antitubercular Agents/pharmacology , Bacterial Proteins/metabolism , Ethambutol/pharmacology , Mycobacterium tuberculosis/drug effects , Tuberculosis/drug therapy , Antitubercular Agents/therapeutic use , Cell Wall/drug effects , Ethambutol/therapeutic use , Humans , Metabolic Networks and Pathways/drug effects , Microbial Sensitivity Tests/methods , Mycobacterium tuberculosis/metabolism , Proteome/drug effects , Proteome/isolation & purification , Time Factors , Tuberculosis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...